Allakos IncNASDAQ:ALLK
- LAST PRICE1.0600
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.0300/ 7
- Ask / Lots1.0900/ 2
- Open / Previous Close0.0000 / 1.0600
- Day Range---
- 52 Week Range
- Volume5
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ALLK |
|---|---|---|
| 09:32 ET | 200 | 1.05 |
| 09:36 ET | 200 | 1.05 |
| 09:39 ET | 100 | 1.05 |
| 09:43 ET | 100 | 1.05 |
| 09:45 ET | 600 | 1.04 |
| 09:48 ET | 200 | 1.045 |
| 09:50 ET | 100 | 1.04 |
| 09:52 ET | 300 | 1.04 |
| 09:54 ET | 300 | 1.04 |
| 09:56 ET | 1169 | 1.04 |
| 09:57 ET | 300 | 1.04 |
| 09:59 ET | 500 | 1.03 |
| 10:01 ET | 1457 | 1.035 |
| 10:03 ET | 200 | 1.035 |
| 10:06 ET | 100 | 1.035 |
| 10:08 ET | 302 | 1.03 |
| 10:10 ET | 100 | 1.035 |
| 10:12 ET | 239 | 1.035 |
| 10:14 ET | 200 | 1.03 |
| 10:15 ET | 600 | 1.04 |
| 10:17 ET | 234 | 1.035 |
| 10:19 ET | 300 | 1.0325 |
| 10:21 ET | 428 | 1.035 |
| 10:24 ET | 296 | 1.035 |
| 10:26 ET | 400 | 1.04 |
| 10:28 ET | 523 | 1.03 |
| 10:30 ET | 300 | 1.035 |
| 10:32 ET | 908 | 1.03 |
| 10:33 ET | 1000 | 1.04 |
| 10:35 ET | 600 | 1.05 |
| 10:37 ET | 520 | 1.0487 |
| 10:39 ET | 200 | 1.045 |
| 10:42 ET | 517 | 1.045 |
| 10:44 ET | 200 | 1.04 |
| 10:46 ET | 13582 | 1.06 |
| 10:48 ET | 211 | 1.055 |
| 10:50 ET | 900 | 1.055 |
| 10:51 ET | 312 | 1.055 |
| 10:53 ET | 100 | 1.06 |
| 10:55 ET | 322 | 1.055 |
| 10:57 ET | 208 | 1.055 |
| 11:00 ET | 200 | 1.05 |
| 11:02 ET | 304 | 1.055 |
| 11:08 ET | 100 | 1.055 |
| 11:11 ET | 100 | 1.055 |
| 11:13 ET | 1218 | 1.055 |
| 11:15 ET | 318 | 1.055 |
| 11:18 ET | 213 | 1.055 |
| 11:22 ET | 330 | 1.055 |
| 11:26 ET | 200 | 1.055 |
| 11:27 ET | 2512 | 1.05 |
| 11:31 ET | 113 | 1.05 |
| 11:33 ET | 200 | 1.05 |
| 11:36 ET | 116 | 1.059 |
| 11:38 ET | 112 | 1.05 |
| 11:40 ET | 100 | 1.05 |
| 11:42 ET | 504 | 1.05 |
| 11:45 ET | 955 | 1.05 |
| 11:47 ET | 102 | 1.05 |
| 11:51 ET | 101 | 1.05 |
| 11:54 ET | 100 | 1.05 |
| 11:58 ET | 200 | 1.06 |
| 12:00 ET | 200 | 1.06 |
| 12:02 ET | 100 | 1.06 |
| 12:03 ET | 2925 | 1.055 |
| 12:05 ET | 100 | 1.06 |
| 12:09 ET | 8044 | 1.055 |
| 12:12 ET | 100 | 1.055 |
| 12:14 ET | 1700 | 1.055 |
| 12:16 ET | 3507 | 1.055 |
| 12:18 ET | 200 | 1.055 |
| 12:20 ET | 1201 | 1.05 |
| 12:21 ET | 300 | 1.055 |
| 12:25 ET | 600 | 1.06 |
| 12:27 ET | 1698 | 1.055 |
| 12:32 ET | 100 | 1.05 |
| 12:34 ET | 3264 | 1.065 |
| 12:38 ET | 2091 | 1.065 |
| 12:39 ET | 3644 | 1.065 |
| 12:41 ET | 100 | 1.065 |
| 12:50 ET | 100 | 1.06 |
| 12:59 ET | 100 | 1.0625 |
| 01:06 ET | 100 | 1.0625 |
| 01:10 ET | 300 | 1.07 |
| 01:14 ET | 200 | 1.065 |
| 01:21 ET | 100 | 1.0625 |
| 01:24 ET | 100 | 1.07 |
| 01:26 ET | 200 | 1.07 |
| 01:28 ET | 300 | 1.0625 |
| 01:30 ET | 9510 | 1.07 |
| 01:32 ET | 100 | 1.07 |
| 01:35 ET | 100 | 1.06 |
| 01:39 ET | 500 | 1.07 |
| 01:42 ET | 300 | 1.06 |
| 01:44 ET | 100 | 1.065 |
| 01:50 ET | 3100 | 1.07 |
| 01:51 ET | 1700 | 1.065 |
| 01:53 ET | 100 | 1.07 |
| 01:55 ET | 2302 | 1.08 |
| 01:57 ET | 300 | 1.08 |
| 02:00 ET | 400 | 1.08 |
| 02:02 ET | 711 | 1.08 |
| 02:08 ET | 300 | 1.08 |
| 02:09 ET | 500 | 1.08 |
| 02:11 ET | 1600 | 1.075 |
| 02:13 ET | 3930 | 1.06 |
| 02:15 ET | 1213 | 1.07 |
| 02:18 ET | 100 | 1.07 |
| 02:20 ET | 800 | 1.07 |
| 02:22 ET | 400 | 1.07 |
| 02:24 ET | 750 | 1.07 |
| 02:26 ET | 100 | 1.07 |
| 02:27 ET | 300 | 1.08 |
| 02:29 ET | 300 | 1.08 |
| 02:31 ET | 928 | 1.08 |
| 02:33 ET | 300 | 1.08 |
| 02:36 ET | 600 | 1.07 |
| 02:38 ET | 400 | 1.08 |
| 02:40 ET | 650 | 1.08 |
| 02:42 ET | 13396 | 1.06 |
| 02:47 ET | 22943 | 1.055 |
| 02:49 ET | 300 | 1.055 |
| 02:51 ET | 200 | 1.055 |
| 02:54 ET | 600 | 1.055 |
| 02:56 ET | 600 | 1.055 |
| 02:58 ET | 1144 | 1.055 |
| 03:02 ET | 900 | 1.055 |
| 03:03 ET | 1856 | 1.055 |
| 03:05 ET | 1412 | 1.055 |
| 03:07 ET | 600 | 1.055 |
| 03:09 ET | 300 | 1.055 |
| 03:12 ET | 1000 | 1.05 |
| 03:14 ET | 11614 | 1.065 |
| 03:16 ET | 1796 | 1.065 |
| 03:18 ET | 800 | 1.065 |
| 03:20 ET | 500 | 1.065 |
| 03:21 ET | 700 | 1.065 |
| 03:23 ET | 300 | 1.06 |
| 03:25 ET | 13022 | 1.055 |
| 03:27 ET | 100 | 1.055 |
| 03:30 ET | 500 | 1.06 |
| 03:32 ET | 600 | 1.06 |
| 03:34 ET | 1556 | 1.055 |
| 03:36 ET | 300 | 1.05 |
| 03:38 ET | 656 | 1.055 |
| 03:39 ET | 200 | 1.05 |
| 03:41 ET | 800 | 1.06 |
| 03:43 ET | 926 | 1.055 |
| 03:45 ET | 1000 | 1.055 |
| 03:48 ET | 6380 | 1.06 |
| 03:50 ET | 1400 | 1.05 |
| 03:52 ET | 3000 | 1.05 |
| 03:54 ET | 2300 | 1.05 |
| 03:56 ET | 2512 | 1.05 |
| 03:57 ET | 6953 | 1.05 |
| 03:59 ET | 5675 | 1.06 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Allakos Inc | 93.1M | -0.5x | --- |
IO Biotech Inc | 94.9M | -0.7x | --- |
DiaMedica Therapeutics Inc | 95.3M | -4.1x | --- |
Anixa Biosciences Inc | 96.0M | -8.7x | --- |
Genelux Corp | 90.0M | -2.8x | --- |
PMV Pharmaceuticals Inc | 89.0M | -1.2x | --- |
Company Information
Allakos Inc. is a clinical-stage biotechnology company, which is engaged in the development of therapeutics that target immunomodulatory receptors present on immune effector cells involved in allergy, inflammatory and proliferative diseases. The Company’s most advanced product candidate, AK006, is in a Phase I clinical trial. AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. It is developing AK006 for the treatment of CSU and potentially other indications. AK006 has completed preclinical testing, and in these studies, it has demonstrated that binding of AK006 to Siglec-6 inhibits multiple modes of mast cell activation, including IgE, IL-33, KIT, C5a and MRGPR-X2. In addition to mast cell inhibition, AK006 reduced human tissue mast cells via ADCP in the presence of activated macrophages. The Company is also developing lirentelimab (AK002) and, in conjunction with the Phase II, lirentelimab results in atopic dermatitis and chronic spontaneous urticaria.
Contact Information
- Headquarters
- 825 INDUSTRIAL ROAD, SUITE 500SAN CARLOS, CA, United States 94070
- Phone
- 650-597-5002
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Daniel Janney
- President
- Adam Tomasi
- Chief Executive Officer, Director
- Robert Alexander
- Chief Financial Officer
- Baird Radford
- Senior Vice President, Chief Compliance Officer, General Counsel, Company Secretary
- Margaret Fitzgerald
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $93.1M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 87.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.84 |
EPS | $-2.14 |
Book Value | $1.92 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
